ConductScience.org, home

Paper19359377

Reduced adiposity and high-fat diet-induced adipose inflammation in mice deficient for phosphodiesterase 4B.

Zhang R and 2 others. Endocrinology, 2009. Cited by 68 papers, by iCite.

Cite this record

ConductScience Library. Reduced adiposity and high-fat diet-induced adipose inflammation in mice deficient for phosphodiesterase 4B. Papers, record 19359377. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19359377

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Reduced adiposity and high-fat diet-induced adipose inflammation in mice deficient for phosphodiesterase 4B.
PubMed
Journal
Endocrinology
PubMed
Year
2009
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
68
iCite
Relative citation ratio, by iCite
1.79
iCite
Revised in PubMed
2024-03-22
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zhang RRen
2Maratos-Flier EEleftheria
3Flier JSJeffrey S

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Adipose Tissue, WhiteMajor topic
AdiposityMajor topic
Cyclic Nucleotide Phosphodiesterases, Type 4Major topic
PanniculitisMajor topic
Adipocytes
Animals
Cell Size
Dietary Fats
Energy Metabolism
Leptin
Male
Mice
Motor Activity
Tumor Necrosis Factor-alpha

Source PubMed

Download CSV of topics

Grants5

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
P01 DK056116NIDDK NIH HHSUnited StatesP01DK056116PubMed and NIHNIH RePORTER
P01 DK56116NIDDK NIH HHSUnited StatesP01DK056116PubMed and NIHNIH RePORTER
R01 DK56113NIDDK NIH HHSUnited StatesR01DK056113PubMed and NIHNIH RePORTER
DK R37 28082NIDDK NIH HHSUnited StatesPubMedPubMed
R37DK028082NIHNIH RePORTER

Download CSV of grants

References68

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
18253716Tumor necrosis factor-alpha suppresses insulin-induced tyrosine phosphorylation of insulin receptor and its substrates.J Biol Chem1993https://conductscience.org/library/papers/8253716PubMed
29547887
The multienzyme PDE4 cyclic adenosine monophosphate-specific phosphodiesterase family: intracellular targeting, regulation, and selective inhibition by compounds exerting anti-inflammatory and antidepressant actions.
Adv Pharmacol1998https://conductscience.org/library/papers/9547887PubMed
312032334Induction of the cyclic nucleotide phosphodiesterase PDE4B is essential for LPS-activated TNF-alpha responses.Proc Natl Acad Sci U S A2002https://conductscience.org/library/papers/12032334PubMed
49184477Phosphodiesterase (PDE)4 inhibitors: anti-inflammatory drugs of the future?Trends Pharmacol Sci1997https://conductscience.org/library/papers/9184477PubMed
516828089Reduced PDE4 expression and activity contributes to enhanced catecholamine-induced cAMP accumulation in adipocytes from FOXC2 transgenic mice.FEBS Lett2006https://conductscience.org/library/papers/16828089PubMed
615639300Phosphodiesterase-4 inhibitors for asthma and chronic obstructive pulmonary disease.Lancet2005https://conductscience.org/library/papers/15639300PubMed
78666137Effects of an engineered human anti-TNF-alpha antibody (CDP571) on insulin sensitivity and glycemic control in patients with NIDDM.Diabetes1996https://conductscience.org/library/papers/8666137PubMed
810766253Central nervous system control of food intake.Nature2000https://conductscience.org/library/papers/10766253PubMed
916257373Keynote review: phosphodiesterase-4 as a therapeutic target.Drug Discov Today2005https://conductscience.org/library/papers/16257373PubMed
1011259554Anti-inflammatory and immunomodulatory potential of the novel PDE4 inhibitor roflumilast in vitro.J Pharmacol Exp Ther2001https://conductscience.org/library/papers/11259554PubMed
1110092513Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity.Biochem Biophys Res Commun1999https://conductscience.org/library/papers/10092513PubMed
1210546692Annual deaths attributable to obesity in the United States.JAMA1999https://conductscience.org/library/papers/10546692PubMed
1317167474Inflammation and metabolic disorders.Nature2006https://conductscience.org/library/papers/17167474PubMed
1410730545Phosphodiesterase 4 inhibitors and the treatment of asthma: where are we now and where do we go from here?Drugs2000https://conductscience.org/library/papers/10730545PubMed
1510506827The molecular biology of cyclic nucleotide phosphodiesterases.Prog Nucleic Acid Res Mol Biol1999https://conductscience.org/library/papers/10506827PubMed
1614698276Inflammation: the link between insulin resistance, obesity and diabetes.Trends Immunol2004https://conductscience.org/library/papers/14698276PubMed
1711470607The next generation of PDE4 inhibitors.Curr Opin Chem Biol2001https://conductscience.org/library/papers/11470607PubMed
1818971485The metabolic syndrome.Endocr Rev2008https://conductscience.org/library/papers/18971485PubMed
199877249Adipose tissue as an endocrine and paracrine organ.Int J Obes Relat Metab Disord1998https://conductscience.org/library/papers/9877249PubMed
2011239410Obesity and the regulation of energy balance.Cell2001https://conductscience.org/library/papers/11239410PubMed

See all 68 referencesDownload CSV of references

Cited by41

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 68 citations.

PMIDTitleJournalYearIn PapersSource
41787480A small‑molecule HDAC/PDE modulator activates human adipocyte UCP1 and resolves inflammatory signaling.J Transl Med2026https://conductscience.org/library/papers/41787480PubMed
41586160Therapeutic Strategies for MASH: An Update on Drug Candidates Under Investigation in Late-Phase Clinical Trials.Int J Transl Med (Basel)2025https://conductscience.org/library/papers/41586160PubMed
41083256The cAMP-phosphodiesterase PDE4B2 controls peroxisome proliferator-activated receptor γ expression and the initiation of adipogenesis in 3T3-L1 cells.Am J Physiol Endocrinol Metab2025https://conductscience.org/library/papers/41083256PubMed
40717023Posttranslational modifications of phosphodiesterase type 4 enzymes represent novel points for therapeutic targeting.FEBS J2025https://conductscience.org/library/papers/40717023PubMed
39201652The Other Side of the Perfect Cup: Coffee-Derived Non-Polyphenols and Their Roles in Mitigating Factors Affecting the Pathogenesis of Type 2 Diabetes.Int J Mol Sci2024https://conductscience.org/library/papers/39201652PubMed
38929716The Intersection of the Pathogenic Processes Underlying Psoriasis and the Comorbid Condition of Obesity.Life (Basel)2024https://conductscience.org/library/papers/38929716PubMed
38878273Therapeutic perspectives on PDE4B inhibition in adipose tissue dysfunction and chronic liver injury.Expert Opin Ther Targets2024https://conductscience.org/library/papers/38878273PubMed
38747241The role of compartmentalized β-AR/cAMP signaling in the regulation of lipolysis in white and brown adipocytes.FEBS J2025https://conductscience.org/library/papers/38747241PubMed
36716599Psoriatic disease and non-alcoholic fatty liver disease shared pathogenesis review.Semin Arthritis Rheum2023https://conductscience.org/library/papers/36716599PubMed
36225204Editorial: Adipocyte differentiation, pluripotency and molecular mechanisms.Front Endocrinol (Lausanne)2022https://conductscience.org/library/papers/36225204PubMed
36142518The Complexity and Multiplicity of the Specific cAMP Phosphodiesterase Family: PDE4, Open New Adapted Therapeutic Approaches.Int J Mol Sci2022https://conductscience.org/library/papers/36142518PubMed
35941833Cancer cell-derived exosomal miR-425-3p induces white adipocyte atrophy.Adipocyte2022https://conductscience.org/library/papers/35941833PubMed
35739982Resveratrol in Treating Diabetes and Its Cardiovascular Complications: A Review of Its Mechanisms of Action.Antioxidants (Basel)2022https://conductscience.org/library/papers/35739982PubMed
35300435Apremilast in the Treatment of Plaque Psoriasis: Differential Use in Psoriasis.Clin Cosmet Investig Dermatol2022https://conductscience.org/library/papers/35300435PubMed
34986332FGF1 and insulin control lipolysis by convergent pathways.Cell Metab2022https://conductscience.org/library/papers/34986332PubMed
34163436Roflumilast Suppresses Adipogenic Differentiation via AMPK Mediated Pathway.Front Endocrinol (Lausanne)2021https://conductscience.org/library/papers/34163436PubMed
33862029Converging vulnerability factors for compulsive food and drug use.Neuropharmacology2021https://conductscience.org/library/papers/33862029PubMed
33498469Effects of Early-Life Stress, Postnatal Diet Modulation and Long-Term Western-Style Diet on Peripheral and Central Inflammatory Markers.Nutrients2021https://conductscience.org/library/papers/33498469PubMed
33153226Role of Phosphodiesterase in the Biology and Pathology of Diabetes.Int J Mol Sci2020https://conductscience.org/library/papers/33153226PubMed
32149342A compendium of G-protein-coupled receptors and cyclic nucleotide regulation of adipose tissue metabolism and energy expenditure.Clin Sci (Lond)2020https://conductscience.org/library/papers/32149342PubMed

See all 41 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/19359377

GET https://conductscience.org/api/papers/v1/19359377/references?page=2